Pharvaris N.V. 4

Lu Peng, President of Pharvaris N.V., exercised 15,000 stock options at $2.59 and sold 15,000 common shares at about $40.68 per share in a cashless transaction under a Rule 10b5-1 plan.

On September 8, 2026, Lu Peng, President of Pharvaris N.V., exercised 15,000 stock options with a strike price of $2.59 per share, acquiring 15,000 shares of common stock for an aggregate exercise cost of approximately $38,850, and simultaneously executed a cashless sale of the same 15,000 shares at a weighted average price of $40.6756 per share for total proceeds of roughly $610,134 under a pre-arranged Rule 10b5-1 trading plan. Following these transactions, which reflect routine option exercise and sale activity rather than an open-market purchase or discretionary sale, Peng’s direct holdings increased from 65,179 to 80,179 shares before the sale and then settled at 65,179 shares of common stock, with the exercised option for 15,000 shares shown as fully exercised and removed from the derivative holdings. Based on the reported sale price as a proxy for current market value, Peng’s post-transaction common stock holdings are worth approximately $2.65 million.

Filing Facts

CIK

1830487

Ticker

PHVS

Form

4

Source Type

fda

Accession

0001193125-26-386096

Alert Tier

6